360 related articles for article (PubMed ID: 26408168)
1. Endocannabinoids and Metabolic Disorders.
Gatta-Cherifi B; Cota D
Handb Exp Pharmacol; 2015; 231():367-91. PubMed ID: 26408168
[TBL] [Abstract][Full Text] [Related]
2. New insights on the role of the endocannabinoid system in the regulation of energy balance.
Gatta-Cherifi B; Cota D
Int J Obes (Lond); 2016 Feb; 40(2):210-9. PubMed ID: 26374449
[TBL] [Abstract][Full Text] [Related]
3. Second generation CB1 receptor blockers and other inhibitors of peripheral endocannabinoid overactivity and the rationale of their use against metabolic disorders.
Silvestri C; Di Marzo V
Expert Opin Investig Drugs; 2012 Sep; 21(9):1309-22. PubMed ID: 22780328
[TBL] [Abstract][Full Text] [Related]
4. MECHANISMS IN ENDOCRINOLOGY: Endocannabinoids and metabolism: past, present and future.
Simon V; Cota D
Eur J Endocrinol; 2017 Jun; 176(6):R309-R324. PubMed ID: 28246151
[TBL] [Abstract][Full Text] [Related]
5. The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders.
Silvestri C; Di Marzo V
Cell Metab; 2013 Apr; 17(4):475-90. PubMed ID: 23562074
[TBL] [Abstract][Full Text] [Related]
6. The endocannabinoid system, eating behavior and energy homeostasis: the end or a new beginning?
Bermudez-Silva FJ; Viveros MP; McPartland JM; Rodriguez de Fonseca F
Pharmacol Biochem Behav; 2010 Jun; 95(4):375-82. PubMed ID: 20347862
[TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome.
Vemuri VK; Janero DR; Makriyannis A
Physiol Behav; 2008 Mar; 93(4-5):671-86. PubMed ID: 18155257
[TBL] [Abstract][Full Text] [Related]
8. The Endocannabinoid System: Pivotal Orchestrator of Obesity and Metabolic Disease.
Mazier W; Saucisse N; Gatta-Cherifi B; Cota D
Trends Endocrinol Metab; 2015 Oct; 26(10):524-537. PubMed ID: 26412154
[TBL] [Abstract][Full Text] [Related]
9. Energy balance regulation by endocannabinoids at central and peripheral levels.
Quarta C; Mazza R; Obici S; Pasquali R; Pagotto U
Trends Mol Med; 2011 Sep; 17(9):518-26. PubMed ID: 21816675
[TBL] [Abstract][Full Text] [Related]
10. Endocannabinoid control of food intake and energy balance.
Di Marzo V; Matias I
Nat Neurosci; 2005 May; 8(5):585-9. PubMed ID: 15856067
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid receptors as therapeutic targets for obesity and metabolic diseases.
Bellocchio L; Mancini G; Vicennati V; Pasquali R; Pagotto U
Curr Opin Pharmacol; 2006 Dec; 6(6):586-91. PubMed ID: 17027338
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes.
Di Marzo V; Piscitelli F; Mechoulam R
Handb Exp Pharmacol; 2011; (203):75-104. PubMed ID: 21484568
[TBL] [Abstract][Full Text] [Related]
13. Understanding metabolic homeostasis and imbalance: what is the role of the endocannabinoid system?
Kunos G
Am J Med; 2007 Sep; 120(9 Suppl 1):S18-24; discussion S24. PubMed ID: 17720356
[TBL] [Abstract][Full Text] [Related]
14. Minireview: Endocannabinoids and their receptors as targets for obesity therapy.
de Kloet AD; Woods SC
Endocrinology; 2009 Jun; 150(6):2531-6. PubMed ID: 19372200
[TBL] [Abstract][Full Text] [Related]
15. The endocannabinoid system and energy metabolism.
Bellocchio L; Cervino C; Pasquali R; Pagotto U
J Neuroendocrinol; 2008 Jun; 20(6):850-7. PubMed ID: 18601709
[TBL] [Abstract][Full Text] [Related]
16. [A role for the endocannabinoid system in obesity].
Valenzuela C; Aguirre C; Castillo V; Ronco AM; Llanos M
Rev Med Chil; 2010 May; 138(5):621-9. PubMed ID: 20668819
[TBL] [Abstract][Full Text] [Related]
17. Endocannabinoids and Their Pharmacological Actions.
Pertwee RG
Handb Exp Pharmacol; 2015; 231():1-37. PubMed ID: 26408156
[TBL] [Abstract][Full Text] [Related]
18. Role of the endocannabinoid system in energy balance regulation and obesity.
Cota D
Front Horm Res; 2008; 36():135-145. PubMed ID: 18230900
[TBL] [Abstract][Full Text] [Related]
19. The role of the endocannabinoid system in eating disorders: pharmacological implications.
Marco EM; Romero-Zerbo SY; Viveros MP; Bermudez-Silva FJ
Behav Pharmacol; 2012 Sep; 23(5-6):526-36. PubMed ID: 22785439
[TBL] [Abstract][Full Text] [Related]
20. Role of the endocannabinoid system in management of patients with type 2 diabetes mellitus and cardiovascular risk factors.
Davis SN; Perkins JM
Endocr Pract; 2007; 13(7):790-804. PubMed ID: 18194939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]